|
|
 |
May 20, 2008 |
Now Available:
Download the podcast of Dr. Peterfy's presentation
With biweekly and special edition newsletters, Musculoskeletal Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment.
MSK Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts. With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.
MSK Video Report:
Charles Peterfy, MD, PhD presents "MRI as an Entry and Outcome Measure for RA Clinical Trials" at the ISEMIR Conference
| MSK Poll | |
|
In which format would you like education on Pulmonary Arterial Hypertension (PAH) to help you manage your patients? |
|
AACE 2008: AACE Experts Warn of Vitamin D Problems in Vegans, Urge Routine Monitoring in Osteoporosis Patients
Vitamin D deficiency research reported at the 2008 American Association for Clinical Endocrinology meetings included a warning about vegan diets, evidence that osteoporosis patients in treatment are still not getting enough vitamin D, and evidence that even a hip fracture does not lead to adequate vitamin D therapy...
Arthritis: Is "Diarthritis" the New Epidemic? Maybe
We've heard of diabesity (the converging epidemic of diabetes and obesity) and now doctors may be seeing more diarthritis (diabetes plus arthritis) in their patients...
Consumer News: Drug Works Well for Moderate-to-Severe Psoriasis
Ustekinumab injections are an efficient long-term treatment for moderate-to-severe psoriasis...
BioPharm Business: Warner Chilcott, LEO Pharma Report FDA Approves Taclonex Scalp, a Once-Daily Therapy for Treatment of Moderate-to-Severe Scalp Psoriasis
The US FDA has approved the new drug application for Taclonex Scalp topical suspension for the treatment of moderate-to-severe psoriasis vulgaris of the scalp in adults...
BioPharm Business: Centocor Alerts Authorized Distributors and Prescribing Physicians About Stolen Infliximab (Remicade)
A transport trailer carrying infliximab (Remicade) was stolen en route to a specialty distributor on May 6, 2008...
BioPharm Business: ChemoCentryx Initiates Phase I Clinical Trial of CCR1 Inhibitor CCX354 for Inflammatory Disease; Milestone Triggers $10 Million Payment From Partner GSK
ChemoCentryx announced the initiation of a phase I clinical trial of CCX354, an orally-available, novel small molecule compound designed to specifically target the CCR1 chemokine receptor associated with inflammatory diseases...